Sapporo, Japan

Masahiro Asaka

This inventor holds 2 USPTO granted patents. Top assignees: Hokkaido University, Tsumura Co., Ltd.. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Asaka. Retrieved from https://idiyas.com/inventor/masahiro-asaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masahiro Asaka: Innovator in Ghrelin Production

Introduction

Masahiro Asaka is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the promotion of ghrelin production. With a total of 2 patents, Asaka's work focuses on enhancing physiological activities related to growth hormone secretion.

Latest Patents

Asaka's latest patents include a ghrelin production promoter. The primary objective of this invention is to identify a substance or composition that can effectively promote the production of ghrelin, which is known for its physiological activities, including the stimulation of growth hormone secretion. The pharmaceutical developed from this research comprises Rikkunshi-to as the active ingredient, showcasing Asaka's innovative approach to addressing health-related challenges.

Career Highlights

Throughout his career, Masahiro Asaka has worked with esteemed institutions such as Hokkaido University and Tsumura Co., Ltd. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research on ghrelin production.

Collaborations

Asaka has collaborated with notable colleagues, including Hiroshi Takeda and Ryuuji Takasaki. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Masahiro Asaka's contributions to the field of pharmaceuticals, particularly in ghrelin production, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire future research and development in this important area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…